Axovant Publicizes Preliminary Results of Phase 2 Trial of Nelotanserin
Axovant Sciences has announced the preliminary results of a Phase 2 clinical trial testing the investigational oral drug therapy nelotanserin…
Articles by Patricia Inácio, PhD
Protein May Prevent Death of Neurons in Patients With Parkinson’s, Study Finds
Researchers have discovered that a protein called Nrf2 is capable of maintaining healthy levels of certain proteins linked to Parkinson’s…
Protein in Brain Associated with Different Stages of Parkinson’s Disease, Study Shows
An international post-mortem brain study of Parkinson’s disease shows altered levels of the LRRK2 protein are associated with different stages…
Mild Cognitive Decline in Parkinson’s Linked to Changes in Brain’s Structure
Disruption of the brain’s structural network has been identified as the potential underlying mechanism for the onset of mild cognitive…
Fat-coated Microbubbles May Aid Parkinson’s Treatment by Getting Past Blood-Brain Barrier
Scientists using fat-coated microbubbles have possibly developed away of carrying therapies for Parkinson’s disease directly to areas of the brain where…
Mutation in PINK1 Gene Increases Risk for Early Parkinson’s Disease
Researchers at Mayo Clinic’s campus in Florida have found a genetic mutation that may increase the risk for developing Parkinson’s…
Dopamine-Neurons’ High Energy Requirements Leads to Neuronal Overheating in Parkinson’s Disease
In a new study entitled “Elevated mitochondrial bioenergetics and axonal arborization size are key contributors to the…
Activity of Two Specific Proteins May Result In Parkinson’s Disease
In a new study entitled “VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a…
Scientists Identify Two New Proteins With Key Roles in Parkinson’s Disease
In a new study entitled “Identification of neurodegenerative factors using translatome–regulatory network analysis” scientists at Rockefeller University…
Anti-Malaria Drugs May Offer Protection Against Parkinson’s Disease
In a new study entitled “Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits…